Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany

被引：20

作者：

Hoelzer, S

Steiner, D

Bauer, R

Reiners, C

Farahati, J

Hundahl, SA

Dudeck, J

机构：

[1] Univ Giessen, Inst Med Informat, D-35392 Giessen, Germany

[2] Univ Giessen, Clin Nucl Med, D-35392 Giessen, Germany

[3] Univ Wurzburg, Clin & Policlin Nucl Med, D-97070 Wurzburg, Germany

[4] Amer Coll Surg, Commiss Canc, Chicago, IL USA

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 2000年 / 27卷 / 10期

关键词：

differentiated thyroid cancer; guidelines; radioiodine; treatment;

D O I：

10.1007/s002590000333

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

This prospective, observational study of a cohort of thyroid cancer patients in Germany focusses on the "real-world" practice in the management of thyroid cancer patients. This report includes data from 2376 patients with primary differentiated thyroid carcinoma first diagnosed in the year 1996, The study reveals considerable differences in actual practice concerning surgery and radioiodine treatment. The results indicate that consensus is lacking with respect to the multimodality treatment approach for differentiated thyroid carcinoma. Our analysis represents the most current and comprehensive national assessment of presenting patient characteristics, diagnostic tests, treatment and complications for thyroid cancer.

引用

页码：1465 / 1472

页数：8

共 50 条

[31] Management of radioiodine refractory differentiated thyroid cancer: the Latin American perspective
Pitoia, Fabian
Scheffel, Rafael Selbach
Califano, Ines
Gauna, Alicia
Tala, Hernan
Vaisman, Fernanda
Gonzalez, Alejandro Roman
Hoff, Ana Oliveira
Maia, Ana Luiza
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2024, 25 (01): : 109 - 121
[32] Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice
Capdevila, Jaume
Deandreis, Desiree'
Durante, Cosimo
Leboulleux, Sophie
Luster, Markus
Netea-Maier, Romana
Newbold, Kate
Singer, Susanne
Sykiotis, Gerasimos P.
Bartes, Beate
Farnell, Kate
Locati, Laura Deborah
EUROPEAN THYROID JOURNAL, 2023, 12 (05)
[33] Current issues in the management of differentiated thyroid cancer
Mallick, UK
Charalambous, H
NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (09) : 873 - 881
[34] Radioiodine for High Risk and Radioiodine Refractory Thyroid Cancer: Current Concepts in Management
Newbold, K. L.
Flux, G.
Wadsley, J.
CLINICAL ONCOLOGY, 2017, 29 (05) : 307 - 309
[35] Current Standards in Treatment of Radioiodine Refractory Thyroid Cancer
Sujata Narayanan
A. Dimitrios Colevas
Current Treatment Options in Oncology, 2016, 17
[36] Current Standards in Treatment of Radioiodine Refractory Thyroid Cancer
Narayanan, Sujata
Colevas, A. Dimitrios
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (06)
[37] Radioiodine treatment after surgery for differentiated thyroid cancer: a reasonable option
Jérôme Clerc
Frederik A. Verburg
Anca M. Avram
Luca Giovanella
Elif Hindié
David Taïeb
European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 918 - 925
[38] Radioiodine treatment of differentiated thyroid cancer related to guidelines and scientific literature
Estorch, M.
Mitjavila, M.
Muros, M. A.
Caballero, E.
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2019, 38 (03): : 195 - 203
[39] Radioiodine treatment after surgery for differentiated thyroid cancer: a reasonable option
Clerc, Jerome
Verburg, Frederik A.
Avram, Anca M.
Giovanella, Luca
Hindie, Elif
Taieb, David
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (06) : 918 - 925
[40] THE EVPI OF TREATMENT STRATEGIES FOR RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCER
Huang, W.
Chen, L.
Ting, J.
Cao, V
Sung, H.
Yokokura, M.
Wilson, L.
VALUE IN HEALTH, 2016, 19 (07) : A886 - A886

← 1 2 3 4 5 →